Close Menu

NEW YORK (GenomeWeb) – Pillar Biosciences announced a strategic partnership and joint venture with China Biotech Services Holdings today that is aimed at the precision diagnostics market in Asia.

Pillar Bio will create a JV with Central Laboratory, a subsidiary of China Biotech Services, to provide precision diagnostic products and services to Hong Kong, Macau, South Korea, and Southeast Asia. Additionally, the JV will distribute Pillar Bio's products, including the SLIMamp and Pivat-based cancer panels, in parts of China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.